HomeCliniciansMigraine prevention prescribing

Migraine prevention prescribing

📋 Sources: PBS criteria — pbs.gov.au. Clinical overview — Australian Prescriber, Apr 2025. MBS items — MBS Book July 2026. Verified June 2026; criteria change — confirm before prescribing.
Reference for health professionals, not prescribing advice.

PBS access, the Authority process, billing and infusion logistics for anti-CGRP treatments. Does not cover dosing, patient selection or comparative choice — those link out.

Reference only — not prescribing advice. PBS criteria for anti-CGRP treatments have changed several times. Verified June 2026. Confirm current criteria at pbs.gov.au, dosing at the TGA PI.

PBS landscape

ClassRoutePBS indicationPBS
Anti-CGRP ligand mAbSC self-injection (monthly/quarterly)Chronic migraine; one also HFEMListed (Authority)
Anti-CGRP ligand mAbIV infusion every 12 wkChronic migraineListed (Authority)
Anti-CGRP receptor mAbSC self-injection (monthly)TGA-approved, migraineNot listed

Class-level, not brand-specific. Gepants: PBS status varies — verify at pbs.gov.au.

✅ Authority readiness checklist

Tap to mark off as you go. Based on published PBS criteria — confirm current wording at pbs.gov.au before applying.

0 of 6 documented

📋 Copy documentation scaffold to notes

Billing

No MBS item specific to anti-CGRP prescribing or migraine infusion.

MBS items verified MBS Book July 2026. If your practice already runs iron infusions, the infrastructure is largely in place — the additional step is the product-specific infusion protocol (see TGA PI).

Not covered here — clinical decisions for you and the source documents:

You might also like

For patients: Migraine prevention — PBS access & cost →
The patient-facing companion: eligibility indicator, cost, what to expect.
IV Iron Post-Infusion Monitoring →
Same clinic setup — anaphylaxis protocol, observation, documentation.
PBS Restrictions Explained →
How Authority, Streamlined and Restricted Benefit listings work.